Figures computed from official regulatory filings — .
Analysttarget 93.5 USD (+23%)
Ownershipinsiders 7.71% · institutions 107.57% · short 37.8% of float
In USD · as of Oct 5, 2026
Ask the machine
Search and compare insider transactions, companies and their statistics in plain language. Your question becomes a query over available data, not a conversation or investment advice.
Data for GeneDx Holdings Corp. only. No web search. Global per-insider statistics are excluded.
An executed search uses one credit, even with no results. Errors and unsupported questions use no credits.
GeneDx Holdings Corp., a genomics company, provides genetic testing services. The company primarily offers pediatric and rare disease diagnostics with a focus on whole exome and genome sequencing, as well as data and information services. It also develops an AI-based platform for next generation sequencing analysis, interpretation, and clinical reporting for rare disease, hereditary risk, and cancer testing. GeneDx Holdings Corp. was founded in 2000 and is headquartered in Stamford, Connecticut.
Market information source · Oct 5, 2026
Periods recorded in the consulted sources. These do not certify the legal dates of name changes.
SEC company identity · Oct 5, 2026
Open-market timeline · full history
68 buys384 sells— close pricebar = usd volume, √ scaleclick a period to filter the table
| Insider | Type | Value · USD | Signals | Details | |
|---|---|---|---|---|---|
| Feeley Kevin | Sell | $5K | SEC | ||
| Stueland Katherine |
| Sell |
| $14.1K |
| SEC |
| Stueland Katherine | ExerciseD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Stueland Katherine | Sell | $155.3K | SEC |
| Feeley Kevin | Sell | $55.2K | SEC |
| Stueland Katherine | Sell | $147.8K | SEC |
| Feeley Kevin | Sell | $106.8K | SEC |
| Feeley Kevin | ExerciseD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Fuchs Thomas | Exercise | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Stueland Katherine | Exercise | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Feeley Kevin | Sell | $144.5K | SEC |
| Fuchs Thomas | ExerciseD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Stueland Katherine | Sell | $406.9K | SEC |
| Feeley Kevin | Exercise | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Stueland Katherine | Sell | $300.8K | SEC |
| Feeley Kevin | Sell | $52.4K | SEC |
| Feeley Kevin | ExerciseD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Stueland Katherine | ExerciseD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Feeley Kevin | Exercise | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Stueland Katherine | Exercise | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Feeley Kevin | Sell | $108.2K | SEC |
| Stueland Katherine | Sell | $310.9K | SEC |
| Feeley Kevin | Exercise | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Feeley Kevin | ExerciseD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Feeley Kevin | Sell | $31.2K | SEC |